litlas
ログインアカウント作成

Gary K. Schwartz

1978–2025 年に発表

175
論文数
32,821
被引用数
97
h 指数
171
i10 指数

被引用数

Gary K. Schwartz の年別被引用数1979 年: 被引用 1 件1980 年: 被引用 2 件1981 年: 被引用 1 件1983 年: 被引用 2 件1984 年: 被引用 1 件1985 年: 被引用 3 件1986 年: 被引用 3 件1987 年: 被引用 5 件1988 年: 被引用 1 件1989 年: 被引用 5 件1990 年: 被引用 4 件1991 年: 被引用 5 件1992 年: 被引用 8 件1993 年: 被引用 7 件1994 年: 被引用 11 件1995 年: 被引用 7 件1996 年: 被引用 10 件1997 年: 被引用 14 件1998 年: 被引用 24 件1999 年: 被引用 31 件2000 年: 被引用 47 件2001 年: 被引用 52 件2002 年: 被引用 71 件2003 年: 被引用 92 件2004 年: 被引用 51 件2005 年: 被引用 99 件2006 年: 被引用 93 件2007 年: 被引用 103 件2008 年: 被引用 145 件2009 年: 被引用 160 件2010 年: 被引用 214 件2011 年: 被引用 227 件2012 年: 被引用 198 件2013 年: 被引用 274 件2014 年: 被引用 276 件2015 年: 被引用 297 件2016 年: 被引用 432 件2017 年: 被引用 562 件2018 年: 被引用 442 件2019 年: 被引用 1,205 件2020 年: 被引用 1,361 件2021 年: 被引用 1,367 件2022 年: 被引用 1,050 件2023 年: 被引用 870 件2024 年: 被引用 1,249 件2025 年: 被引用 708 件2026 年: 被引用 20 件1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,238 件、この内訳の 27.4%中国: 引用元論文 2,260 件、この内訳の 14.6%イギリス: 引用元論文 787 件、この内訳の 5.1%イタリア: 引用元論文 704 件、この内訳の 4.6%ドイツ: 引用元論文 702 件、この内訳の 4.5%フランス: 引用元論文 598 件、この内訳の 3.9%日本: 引用元論文 528 件、この内訳の 3.4%スペイン: 引用元論文 430 件、この内訳の 2.8%カナダ: 引用元論文 420 件、この内訳の 2.7%オランダ: 引用元論文 419 件、この内訳の 2.7%オーストラリア: 引用元論文 410 件、この内訳の 2.7%インド: 引用元論文 326 件、この内訳の 2.1%
0%27.4%その他 23.5%

機関

分野

  • Medicine47.5%
  • Biochemistry, Genetics and Molecular Biology43.8%
  • Immunology and Microbiology3.2%
  • Engineering0.8%
  • Computer Science0.7%
  • Chemistry0.7%
  • その他3.3%

トピック

  • Extracellular vesicles in disease7.5%
  • MicroRNA in disease regulation5.1%
  • Sarcoma Diagnosis and Treatment3.2%
  • Cancer-related Molecular Pathways2.6%
  • RNA Interference and Gene Delivery2.3%
  • Cancer Immunotherapy and Biomarkers2.3%
  • その他77%

共著者

全論文

検索で開く
  1. Tumour exosome integrins determine organotropic metastasis

    著者: Ayuko Hoshino, Bruno Costa‐Silva, Tang‐Long Shen, Gonçalo Rodrigues, Ayako Hashimoto, Milica Tešić Mark, Henrik Molina, Shinji Kohsaka, Angela Di Giannatale, Sophia Ceder, Swarnima Singh, Caitlin Williams, Nadine Soplop, Kunihiro Uryu, Lindsay A. Pharmer, Tari A. King, Linda Bojmar, Alexander E. Davies, Yonathan Ararso, Tuo Zhang, Haiying Zhang, Jonathan M. Hernandez, Joshua M. Weiss, Vanessa D Dumont-Cole, Kimberly Kramer, Leonard H. Wexler, Aru Narendran, Gary K. Schwartz, John H. Healey, Per Sandström, Knut Jørgen Labori, Elin H. Kure, Paul M. Grandgenett, Michael A. Hollingsworth, Maria de Sousa, Sukhwinder Kaur, Maneesh Jain, Kavita Mallya, Surinder K. Batra, William R. Jarnagin, Mary S. Brady, Øystein Fodstad, Volkmar Muller, Klaus Pantel, Andy J. Minn, Mina J. Bissell, Benjamin A. García, Yibin Kang, Vinagolu K. Rajasekhar, Cyrus M. Ghajar, Irina Matei, Héctor Peinado, Jacqueline Bromberg, David Lyden - Nature 2015 被引用: 5,185

  2. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

    著者: Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak, Mark Agulnik, Steven Attia, Jean‐Yves Blay, Irene Carrasco García, John A. Charlson, Edwin Choy, George D. Demetri, Mihaela Druta, Édouard Forcade, Kristen N. Ganjoo, John Glod, Vicki L. Keedy, Axel Le Cesne, David A. Liebner, Víctor Moreno, Seth M. Pollack, Scott M. Schuetze, Gary K. Schwartz, Sandra J. Strauss, William D. Tap, Fiona Thistlethwaite, Claudia Maria Valverde Morales, Michael J. Wagner, Breelyn A. Wilky, Cheryl McAlpine, Laura Hudson, Jean‐Marc Navenot, Tianjiao Wang, Jane P. F. Bai, Stavros Rafail, Ruoxi Wang, Amy Sun, Lilliam Fernandes, Erin Van Winkle, Erica Elefant, Colin Lunt, Elliot Norry, Dennis Williams, Swethajit Biswas, Brian Andrew Van Tine - The Lancet 2024 被引用: 263

  3. Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

    著者: Sandra P. D’Angelo, Michelle R. Mahoney, Brian Andrew Van Tine, James N. Atkins, Mohammed Milhem, Balkrishna Jahagirdar, Cristina R. Antonescu, Elise Horvath, William D. Tap, Gary K. Schwartz, Howard Streicher - The Lancet Oncology 2018 被引用: 748

  4. Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

    著者: Jana Biermann, Johannes C. Melms, Amit Dipak Amin, Yiping Wang, Lindsay Caprio, Alcida Karz, Somnath Tagore, Irving Barrera, Miguel A. Ibarra-Arellano, Massimo Andreatta, Benjamin T. Fullerton, Kristjan H. Gretarsson, Varun Sahu, Vaibhav S. Mangipudy, Trang Nguyen, Ajay Nair, Meri Rogava, Patricia Ho, Peter D. Koch, Matei A. Banu, Nelson Humala, Aayushi Mahajan, Zachary Walsh, Shivem B. Shah, Daniel H. Vaccaro, Blake Caldwell, Michael Mu, Florian Wünnemann, Margot Chazotte, Simon Berhe, Adrienne Luoma, Joseph Driver, Matthew Ingham, Shaheer Khan, Suthee Rapisuwon, Craig L. Slingluff, Thomas Eigentler, Martin Röcken, Richard D. Carvajal, Michael B. Atkins, Michael A. Davies, Albert S. Agustinus, Samuel F. Bakhoum, Elham Azizi, Markus D. Siegelin, Chao Lü, Santiago J. Carmona, Hanina Hibshoosh, Antoni Ribas, Peter Canoll, Jeffrey N. Bruce, Wenya Linda Bi, Praveen Agrawal, Denis Schapiro, Eva Hernando, Evan Z. Macosko, Fei Chen, Gary K. Schwartz, Benjamin Izar - Cell 2022 被引用: 219

  5. First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

    著者: Josep Tabernero, Geoffrey I. Shapiro, Patricia LoRusso, Andrés Cervantes, Gary K. Schwartz, Glen J. Weiss, Luis Paz‐Ares, Daniel C. Cho, Jeffrey R. Infante, María Alsina, Mrinal M. Gounder, Rick Falzone, Jamie Harrop, Amy C. Seila White, Iva Toudjarska, David Bumcrot, Rachel Meyers, Gregory Hinkle, Nenad Svrzikapa, Renta Hutabarat, Valerie A. Clausen, Jeffrey Cehelsky, Saraswathy V. Nochur, Christina Gamba‐Vitalo, Akshay Vaishnaw, Dinah W.Y. Sah, Jared Gollob, Howard A. Burris - Cancer Discovery 2013 被引用: 699

  6. Atezolizumab for Advanced Alveolar Soft Part Sarcoma

    著者: Alice P. Chen, Elad Sharon, Geraldine O’Sullivan Coyne, Nancy Moore, Jared C. Foster, James Hu, Brian A. Van Tine, Anthony P. Conley, William L. Read, Richard F. Riedel, Melissa Burgess, John Glod, Elizabeth J. Davis, Priscilla Merriam, Abdul Rafeh Naqash, Kristin Fino, Brandon Miller, Deborah Wilsker, Asma Begum, Katherine V. Ferry‐Galow, Hari A. Deshpande, Gary K. Schwartz, Brian H. Ladle, Scott H. Okuno, Jill C. Beck, James L. Chen, Naoko Takebe, Laura K. Fogli, Christina L. Rosenberger, Ralph E. Parchment, James H. Doroshow - New England Journal of Medicine 2023 被引用: 152

  7. Sorafenib for Advanced and Refractory Desmoid Tumors

    著者: Mrinal M. Gounder, Michelle R. Mahoney, Brian A. Van Tine, Vinod Ravi, Steven Attia, Hari A. Deshpande, Abha A. Gupta, Mohammed Milhem, Robert M. Conry, Sujana Movva, Michael J. Pishvaian, Richard F. Riedel, Tarek Sabagh, William D. Tap, Natally Horvat, Ethan Basch, Lawrence H. Schwartz, Robert G. Maki, Narasimhan P. Agaram, Robert A. Lefkowitz, Yousef Mazaheri, Rikiya Yamashita, John J. Wright, Amylou C. Dueck, Gary K. Schwartz - New England Journal of Medicine 2018 被引用: 449

  8. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

    著者: Mrinal M. Gounder, Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis, Anita Krishnan, Jessica Lee, Steven Attia, Wassim Abida, Alexander Drilon, Ping Chi, Sandra P. D’ Angelo, Mark A. Dickson, Mary Lou Keohan, Ciara M. Kelly, Mark Agulnik, Sant P. Chawla, Edwin Choy, Rashmi Chugh, Christian F. Meyer, Parvathi A. Myer, Jessica L. Moore, Ross A. Okimoto, Raphael E. Pollock, Vinod Ravi, Arun S. Singh, Neeta Somaiah, Andrew J. Wagner, John H. Healey, Garrett M. Frampton, Jeffrey M. Venstrom, Jeffrey S. Ross, Marc Ladanyi, Samuel Singer, Murray F. Brennan, Gary K. Schwartz, Alexander J. Lazar, David M. Thomas, Robert G. Maki, William D. Tap, Siraj M. Ali, Dexter X. Jin - Nature Communications 2022 被引用: 193

  9. Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial

    著者: Andrea J. Bullock, Benjamin L. Schlechter, Marwan Fakih, Apostolia M. Tsimberidou, Joseph E. Grossman, Michael S. Gordon, Breelyn A. Wilky, Agustin Pimentel, Daruka Mahadevan, Ani Sarkis Balmanoukian, Rachel E. Sanborn, Gary K. Schwartz, Ghassan K. Abou‐Alfa, Neil H Segal, Bruno Bockorny, Justin C. Moser, Sunil Sharma, Jaymin Patel, Wei Wu, Dhan Chand, Katherine Rosenthal, Gabriel Mednick, Chloé Delépine, Tyler J. Curiel, Justin Stebbing, Heinz‐Josef Lenz, Steven O’Day, Anthony B. El-Khoueiry - Nature Medicine 2024 被引用: 110

  10. A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas

    著者: Mrinal M. Gounder, Todd M. Bauer, Gary K. Schwartz, Amy Weise, Patricia LoRusso, Prasanna Kumar, Ben Tao, Ying Hong, Parul Patel, Yasong Lu, Arnaud Lesegretain, Vijaya G. Tirunagaru, Feng Xu, Robert C. Doebele, David S. Hong - Journal of Clinical Oncology 2023 被引用: 91

  11. Targeting the Cell Cycle: A New Approach to Cancer Therapy

    著者: Gary K. Schwartz, Manish A. Shah - Journal of Clinical Oncology 2005 被引用: 824

  12. Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

    著者: Yiping Wang, Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera, Patricia Ho, Somnath Tagore, Gabriel Abril-Rodríguez, Siyu He, Yinuo Jin, Jana Biermann, Matan Hofree, Lindsay Caprio, Simon Berhe, Shaheer Khan, Brian S. Henick, Antoni Ribas, Evan Z. Macosko, Fei Chen, Alison M. Taylor, Gary K. Schwartz, Richard D. Carvajal, Elham Azizi, Benjamin Izar - Nature Genetics 2023 被引用: 59

  13. Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

    著者: Richard D. Carvajal, Sophie Piperno‐Neumann, Ellen Kapiteijn, Paul B. Chapman, Stephen Jay Frank, Anthony M. Joshua, Josep M. Piulats, Pascal Wolter, Véronique Cocquyt, Bartosz Chmielowski, T.R. Jeffry Evans, Lauris Gastaud, Gerald P. Linette, Carola Berking, Jacob Schachter, Manuel Rodrigues, Alexander N. Shoushtari, Delyth Clemett, Dana Ghiorghiu, G Mariani, Shirley Spratt, Susan Lovick, Peter Barker, Elaine Kilgour, Zhongwu Lai, Gary K. Schwartz, Paul Nathan - Journal of Clinical Oncology 2018 被引用: 275

  14. Cell-Cycle Therapeutics Come of Age

    著者: Matthew Ingham, Gary K. Schwartz - Journal of Clinical Oncology 2017 被引用: 395

  15. Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib

    著者: Mark A. Dickson, Gary K. Schwartz, Mary Louise Keohan, Sandra P. D’Angelo, Mrinal M. Gounder, Ping Chi, Cristina R. Antonescu, Jonathan Landa, Li‐Xuan Qin, Aimeé M. Crago, Samuel Singer, Andrew Koff, William D. Tap - JAMA Oncology 2016 被引用: 324

  16. Metastatic disease from uveal melanoma: treatment options and future prospects

    著者: Richard D. Carvajal, Gary K. Schwartz, Tongalp H. Tezel, Brian P. Marr, Jasmine H. Francis, Paul Nathan - British Journal of Ophthalmology 2016 被引用: 443

  17. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    著者: Jyoti D. Patel, Lada Krilov, Sylvia Adams, Carol Aghajanian, Ethan Basch, Marcia S. Brose, William L. Carroll, Marcos de Lima, Mark R. Gilbert, Mark G. Kris, John L. Marshall, Gregory A. Masters, Steven O’Day, Blasé N. Polite, Gary K. Schwartz, Sunil Sharma, Ian M. Thompson, Nicholas J. Vogelzang, Bruce J. Roth - Journal of Clinical Oncology 2013 被引用: 435

  18. Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

    著者: Ethan Basch, Claus Becker, Lauren J. Rogak, Deborah Schrag, Bryce B. Reeve, Patricia A. Spears, Mary Lou Smith, Mrinal M. Gounder, Michelle R. Mahoney, Gary K. Schwartz, Antonia V. Bennett, Tito R. Mendoza, Charles S. Cleeland, Jeff A. Sloan, Deborah Watkins Bruner, Gisela Schwab, Thomas M. Atkinson, Gita Thanarajasingam, Monica M. Bertagnolli, Amylou C. Dueck - Clinical Trials 2020 被引用: 246

  19. The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design

    著者: Keith T. Flaherty, Robert J. Gray, Alice P. Chen, Shuli Li, David R. Patton, Stanley R. Hamilton, P. Mickey Williams, Edith P. Mitchell, A. John Iafrate, Jeffrey Sklar, Lyndsay N. Harris, Lisa M. McShane, Larry Rubinstein, David Sims, Mark Routbort, Brent Coffey, Tony Fu, James A. Zwiebel, Richard F. Little, Donna M. Marinucci, Robert B. Catalano, Rick Magnan, Warren A. Kibbe, Carol J. Weil, James V. Tricoli, Brian M. Alexander, Shaji Kumar, Gary K. Schwartz, Funda Meric‐Bernstam, Chih‐Jian Lih, Worta McCaskill‐Stevens, Paolo F. Caimi, Naoko Takebe, Vivekananda Datta, Carlos L. Arteaga, Jeffrey S. Abrams, Robert L. Comis, Peter J O’Dwyer, Barbara A. Conley, for the NCI-MATCH Team - JNCI Journal of the National Cancer Institute 2020 被引用: 228

  20. Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma

    著者: Richard D. Carvajal, Jeffrey A. Sosman, J. Fernando Quevedo, Mohammed Milhem, Anthony M. Joshua, Ragini R. Kudchadkar, Gerald P. Linette, Thomas F. Gajewski, Jose Lutzky, David H. Lawson, Christopher D. Lao, Patrick J. Flynn, Mark R. Albertini, Takami Sato, Karl D. Lewis, Austin Doyle, Kristin Kathleen Ancell, Katherine S. Panageas, Mark J. Bluth, Cyrus V. Hedvat, Joseph P. Erinjeri, Grazia Ambrosini, Brian P. Marr, David H. Abramson, Mark A. Dickson, Jedd D. Wolchok, Paul B. Chapman, Gary K. Schwartz - JAMA 2014 被引用: 429

  21. The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity

    著者: Patricia Ho, Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Joanna Poźniak, Shivem B. Shah, Zachary Walsh, Oleksandr Kyrysyuk, Amit Dipak Amin, Lindsay Caprio, Benjamin T. Fullerton, Rajesh K. Soni, Casey R. Ager, Jana Biermann, Yi‐Ping Wang, Mohsen Khosravi‐Maharlooei, Giorgia Zanetti, Michael Mu, Hijab Fatima, Emily K. Moore, Neil Vasan, Samuel F. Bakhoum, Steven L. Reiner, Chantale Bernatchez, Megan Sykes, Emily M. Mace, Kai W. Wucherpfennig, Dirk Schadendorf, Oliver Bechter, Parin Shah, Gary K. Schwartz, Jean‐Christophe Marine, Benjamin Izar - Cancer Cell 2023 被引用: 94

  22. Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC).

    著者: Anthony B. El-Khoueiry, Marwan Fakih, Michael S. Gordon, Apostolia M. Tsimberidou, Andrea J. Bullock, Breelyn A. Wilky, Jonathan C. Trent, Kim Margolin, Daruka Mahadevan, Ani Sarkis Balmanoukian, Rachel E. Sanborn, Gary K. Schwartz, Bruno Bockorny, Justin C. Moser, Joseph E. Grossman, W.I. Ortuzar Feliu, Katherine Rosenthal, Steven O’Day, Heinz‐Josef Lenz, Benjamin L. Schlechter - Journal of Clinical Oncology 2023 被引用: 55

  23. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

    著者: Jordi Barretina, Barry S. Taylor, Shantanu Banerji, Alexis Ramos, Mariana Lagos‐Quintana, Penelope DeCarolis, Kinjal Shah, Nicholas D. Socci, Barbara A. Weir, Alan L. Ho, Derek Y. Chiang, Boris Reva, Craig H. Mermel, Gad Getz, Yevgenyi Antipin, Rameen Beroukhim, John E. Major, Charles Hatton, Richard Nicoletti, Megan Hanna, Ted Sharpe, Tim Fennell, Kristian Cibulskis, Robert C. Onofrio, Tsuyoshi Saito, Neerav Shukla, Christopher Lau, Sven Nelander, Serena J. Silver, Carrie Sougnez, Agnès Viale, Wendy Winckler, Robert G. Maki, Levi A. Garraway, Alex Lash, Heidi Greulich, David E. Root, William R. Sellers, Gary K. Schwartz, Cristina R. Antonescu, Eric S. Lander, Harold Varmus, Marc Ladanyi, Chris Sander, Matthew Meyerson, Samuel Singer - Nature Genetics 2010 被引用: 726

  24. Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer

    著者: Sung Soo Kim, Jessica Armand, Anton Safonov, Mimi Zhang, Rajesh K. Soni, Gary K. Schwartz, Julia E. McGuinness, Hanina Hibshoosh, Pedram Razavi, Minah Kim, Sarat Chandarlapaty, Hee Won Yang - Cell Reports 2023 被引用: 56